Cargando…

Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy

PURPOSE: To evaluate the effect of spironolactone on chronic central serous chorioretinopathy (CSC). METHODS: In this prospective interventional case series, patients with chronic CSC were treated with spironolactone (25 mg daily) for at least 6 weeks. If the subretinal fluid (SRF) had not completel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falavarjani, Khalil Ghasemi, Amirsardari, Anahita, Habibi, Abbas, Eshaghi, Acieh, Bakhti, Shohreh, Aghdam, Kaveh Abri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525497/ https://www.ncbi.nlm.nih.gov/pubmed/28791061 http://dx.doi.org/10.4103/jovr.jovr_139_16

Ejemplares similares

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Naseripour, Masood, et al.
Publicado: (2016)

Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
por: Kapoor, Kapil G., et al.
Publicado: (2017)

An Update on Optical Coherence Tomography Angiography in Diabetic Retinopathy
por: Khadamy, Joobin, et al.
Publicado: (2018)

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study
por: Bousquet, Elodie, et al.
Publicado: (2015)

Erythropoietin in ophthalmology: A literature review
por: Abri Aghdam, Kaveh, et al.
Publicado: (2016)

Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
por: Sinawat, Suthasinee, et al.
Publicado: (2020)

Anterior Segment Study with the Pentacam Scheimpflug Camera in Refractive Surgery Candidates
por: Hashemi, Masih, et al.
Publicado: (2013)

Endophthalmitis caused by Acinetobacter spp. as the presenting manifestation of diabetes mellitus
por: Parvaresh, Mohammad Mehdi, et al.
Publicado: (2016)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Ruiz-del-Tiempo, María Pilar, et al.
Publicado: (2018)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Visual and anatomical outcomes of central serous chorioretinopathy patients presenting to a tertiary unit: a prospective analysis
por: Walkden, Andrew, et al.
Publicado: (2020)

Factors Influencing the Visual Acuity of Chronic Central Serous Chorioretinopathy
por: Kim, Yun Young, et al.
Publicado: (2011)

Factors affecting the visual outcome in acute central serous chorioretinopathy
por: Islam, Qamar Ul, et al.
Publicado: (2017)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Effect of oral eplerenone in anatomical and functional improvement in patients with chronic central serous chorioretinopathy
por: Farooq, Omer, et al.
Publicado: (2019)

Significant Visual Impairment after Short-Lasting Central Serous Chorioretinopathy
por: Gawęcki, Maciej, et al.
Publicado: (2022)

Central serous chorioretinopathy secondary to trauma
por: Jackson, Thomas E., et al.
Publicado: (2012)

Central Serous Chorioretinopathy after Rhinoplasty
por: Moschos, Marilita M., et al.
Publicado: (2010)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Comment on: Traumatic central serous chorioretinopathy
por: Agarwal, Manisha, et al.
Publicado: (2015)

Advances in the treatment of central serous chorioretinopathy
por: Abouammoh, Marwan A.
Publicado: (2015)

Comment on: Traumatic central serous chorioretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2016)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Operating room central serous chorioretinopathy
por: Mansour, Ahmad M, et al.
Publicado: (2017)

Management of chronic central serous chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2018)

Central Serous Chorioretinopathy: Treatment with Laser
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro, Francesco, et al.
Publicado: (2019)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2021)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2022)

CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY
por: Terao, Nobuhiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cmb4vadvuejv4jiv80ugd1tkn7